Summary
In glioblastoma, invasion and proliferation are presumed to be mutually exclusive events; however, the molecular mechanisms that mediate this switch at the cellular level remain elusive. Previously, we have shown that phospho-OLIG2, a Central Nervous System-specific transcription factor, is essential for tumor growth and proliferation. Here, we show that modulation of OLIG2 phosphorylation can trigger a switch between proliferation and invasion. Glioma cells with unphosphorylated OLIG2S10, S13, S14 are highly migratory and invasive both in vitro and in vivo. Mechanistically, unphosphorylated OLIG2 induces TGFβ2 expression and promotes invasive mesenchymal properties in glioma cells. Inhibition of TGFβ2 pathway blocks this OLIG2-dependent invasion. Furthermore, ectopic expression of phosphomimetic Olig2 is sufficient to block TGFβ2 mediated invasion and reduce expression of invasion genes (ZEB1 and CD44). Our results not only provide a mechanistic insight into how cells switch from proliferation to invasion, but also offer therapeutic opportunities for inhibiting dissemination of gliomas.